Tissue Regeneration?
We’re doing it all wrong. To effectively treat lameness conditions in sport and race horses we need a paradigm shift in how these animals are managed by horsemen and veterinarians. Attending the North American Veterinary Regenerative Medicine Conference here in Lexington last week underscored that belief. Here is the quick and dirty of what I learned at that meeting:
Stem cells injected into a joint are not magically finding their way to areas where the cartilage is worn off, and planting themselves there to generate new cartilage. Bummer. I was really hoping there was some possibility here, after other (non-equine) studies showed that stem cells might “home” to injured tissue.
Low numbers of stem cells are found in the area of tendon injury weeks after they are injected. In fact when using standard procedures, stem cells injected into a “tear” in tendons didn’t even fill up the length of the tear at the time of injection: they just hung out around the injection site. Pretty disappointing. This isn’t to say that the cells don’t slowly migrate afterward to areas of injured tissue, which has been shown in previous science, but at least the injection process isn’t as straight forward as we thought. And given the previous information (the cells don’t incorporate themselves significantly into the tendon, even if they get there), migration is fairly moot.
During a break in action, I chatted with a colleague and friend who runs a very successful racetrack practice in Southern California, working on some of our most famous racehorses. He has had trouble finding anything that heals injured tendons with anything greater than 60% success rate. This 60% reflects the success rate of horses with bowed tendons that receive no therapy except time off, making it back to racing at the level where they competed before injury. It’s often possible to bring a horse back with soft tissue injury, to compete at a lesser job. The gold standard would be to heal tissue to the degree that the horse can compete where it was before injury.
So it was with some anticipation that we stepped into the lecture given by Dr Christiana Ober, who gave a nice report on her results of treating horses with soft tissue injuries using the various regenerative modalities: bone marrow, stem cells cultured from bone marrow, stem cells cultured from fat cells, and Platelet Rich Plasma. She did a great job by excluding the lesions which would easily heal on their own, and raised the bar showing real strength of healing, by only calling a positive result those horses who had come back post injury to compete at their previous level for two seasons. This would show not just that the horse made it back, but that the healing was substantial enough to keep the horse at its current job. Combining all the various therapies in her group of treated horses, guess what her overall success rate was. Any guesses?
60%
If you take my friend’s data, this means there was zero effect of regenerative therapies above what Dr Green can give you by turning the horse out in a field. This is a good time to bring up two points that I think are critical to this whole discussion:
1. It’s entirely possible that stem cells will eventually do exactly what we always dreamed of them doing: regenerating brand new, perfectly replicated tendons, ligaments and cartilage, that will join hands with the existing healthy tissue, and become a seamless extension of that tissue, as if there never was an injury. The problem may very well be that this entire field is in its infancy, and we just need more time to learn how to tell these cells to go there and do that. We just aren’t there yet. There is some pretty cool stuff being found in other applications. Dr Scott Morrison presented some cases of severe laminitis that were very near the end, that soon after regional limb perfusion of stem cells started to grow incredibly healthy foot, and may have saved some lives. He can’t say what exactly the stem cells are doing, but something in the soup seems to be sending a signal to create healthy tissue. We just need time and money to figure out specifics so we can optimize that effect.
2. Even if we are able to regenerate the tissue back to 100% of its original strength, we have to remember that this horse got injured with the tissue that God gave it; to go back to the same work program where the horse originally got injured, we need to get new therapies to exceed 100% of original capacity. This is a ridiculous expectation.
Achieving the founatin of youth is not likely to happen in a laboratory; we can spend years developing ways to ”fix” injured tissue to where it was pre-injury, but how will that prevent reinjury even if it’s 100% effective? The answer already exists, and it couldn’t be easier: prevention. This isn’t to say that we just keep talented but fragile horses from competing at levels that put them at risk. Rather, it means that we follow them very carefully, and manage their training and their careers in a way that ensures their tissues are given the opportunity to fortify as the horse progresses.
This requires a good relationship among owner, trainer, veterinarian and farrier. It also demands a willingness for the owner to pay for regular visits by the veterinarian, even when the horse is seemingly sound. Early recognition, an accurate diagnosis, and appropriate management are the cornerstones to long careers in equine athletes. As long as we believe that we can create a miracle in a syringe, there will not be a need for horsemen to pay attention to what their horses are trying to tell them. I submit that there will never be a miracle in a syringe, so we should make every effort to become better listeners.
























Dr. Emerson provides sports medicine services for Rood and Riddle Equine Hospital in Lexington, KY and Wellington, FL.
(Views expressed here do not necessarily reflect those of other veterinarians at RREH.)
Loading...
